Skip to content
OpenCapital
Get started

Ardelyx ARDX Deferred Revenue

Deferred Revenue at other companies

Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$5.04M+9.6%

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%—
Net margin-13.6%—
FCF margin-40.9%—

Returns & leverage

See full
Return on equity-39.5%—
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's deferred revenue?
Ardelyx (ARDX) reported deferred revenue of $3.25M in Q1 2026.
How has Ardelyx's deferred revenue changed year-over-year?
Ardelyx's deferred revenue decreased by 70.2% year-over-year, from $10.91M to $3.25M.
What is the long-term trend for Ardelyx's deferred revenue?
Over 5 years (2020 to 2025), Ardelyx's deferred revenue has grown at a -22.0% compound annual growth rate (CAGR), from $4.18M to $1.21M.
What does deferred revenue mean?
Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.